Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.
1979; Lippincott Williams & Wilkins; Volume: 60; Issue: 6 Linguagem: Inglês
10.1161/01.cir.60.6.1208
ISSN1524-4539
AutoresDouglas R. Rosing, K.M. Kent, B J Maron, Stephen E. Epstein,
Tópico(s)Innovation Policy and R&D
ResumoHomeCirculationVol. 60, No. 6Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyRedditDiggEmail Jump toFree AccessAbstractPDF/EPUBVerapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. D R Rosing, K M Kent, B J Maron and S E Epstein D R RosingD R Rosing , K M KentK M Kent , B J MaronB J Maron and S E EpsteinS E Epstein Originally published1 Dec 1979https://doi.org/10.1161/01.CIR.60.6.1208Circulation. 1979;60:1208–1213 Previous Back to top Next FiguresReferencesRelatedDetailsCited ByMaron B, Maron M, Sherrid M and Rowin E (2022) Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy, Journal of the American Heart Association, 11:9, Online publication date: 3-May-2022. Dybro A, Rasmussen T, Nielsen R, Andersen M, Jensen M and Poulsen S (2021) Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy, Journal of the American College of Cardiology, 10.1016/j.jacc.2021.07.065, 78:25, (2505-2517), Online publication date: 1-Dec-2021. Ommen S, Mital S, Burke M, Day S, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link M, Maron M, Martinez M, Miyake C, Schaff H, Semsarian C, Sorajja P, O'Gara P, Beckman J, Levine G, Al-Khatib S, Armbruster A, Birtcher K, Ciggaroa J, Dixon D, de las Fuentes L, Deswal A, Fleisher L, Gentile F, Goldberger Z, Gorenek B, Haynes N, Hernandez A, Hlatky M, Joglar J, Jones W, Marine J, Mark D, Palaniappan L, Piano M, Tamis-Holland J, Wijeysundera D and Woo Y (2021) 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2021.04.001, 162:1, (e23-e106), Online publication date: 1-Jul-2021. Ommen S, Mital S, Burke M, Day S, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link M, Maron M, Martinez M, Miyake C, Schaff H, Semsarian C and Sorajja P (2020) 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary, Circulation, 142:25, (e533-e557), Online publication date: 22-Dec-2020.Ommen S, Mital S, Burke M, Day S, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link M, Maron M, Martinez M, Miyake C, Schaff H, Semsarian C and Sorajja P (2020) 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy, Circulation, 142:25, (e558-e631), Online publication date: 22-Dec-2020. Ommen S, Mital S, Burke M, Day S, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link M, Maron M, Martinez M, Miyake C, Schaff H, Semsarian C and Sorajja P (2020) 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy, Journal of the American College of Cardiology, 10.1016/j.jacc.2020.08.045, 76:25, (e159-e240), Online publication date: 1-Dec-2020. Ommen S, Mital S, Burke M, Day S, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link M, Maron M, Martinez M, Miyake C, Schaff H, Semsarian C and Sorajja P (2020) 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary, Journal of the American College of Cardiology, 10.1016/j.jacc.2020.08.044, 76:25, (3022-3055), Online publication date: 1-Dec-2020. Mankowitz K and Sherrid M (2019) Medical Therapy: From Beta-Blockers to Disopyramide Hypertrophic Cardiomyopathy, 10.1007/978-3-319-92423-6_15, (199-219), . Andries G, Yandrapalli S, Naidu S and Panza J (2018) Novel Pharmacotherapy in Hypertrophic Cardiomyopathy, Cardiology in Review, 10.1097/CRD.0000000000000211, 26:5, (239-244), Online publication date: 1-Sep-2018. Mankowitz K (2015) Medical Therapy: From Beta–Blockers to Disopyramide Hypertrophic Cardiomyopathy, 10.1007/978-1-4471-4956-9_14, (165-177), . Henein M, Sheppard M and Pepper J (2012) Hypertrophic Cardiomyopathy Clinical Echocardiography, 10.1007/978-1-84882-521-5_10, (187-202), . Ommen S (2011) Hypertrophic Cardiomyopathy, Current Problems in Cardiology, 10.1016/j.cpcardiol.2011.06.001, 36:11, (409-453), Online publication date: 1-Nov-2011. Saito M, Okayama H, Yoshii T, Hiasa G, Sumimoto T, Inaba S, Nishimura K, Inoue K, Ogimoto A, Shigematsu Y, Funada J, Hamada M and Higaki J (2011) Myocardial Fibrosis Attenuates the Effect of Cibenzoline on Left Ventricular Diastolic Function in Patients With Hypertrophic Cardiomyopathy, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0b013e318203830d, 57:2, (207-212), Online publication date: 1-Feb-2011. Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J and Yancy C (2011) 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy, Journal of the American College of Cardiology, 10.1016/j.jacc.2011.06.011, 58:25, (e212-e260), Online publication date: 1-Dec-2011. Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J and Yancy C (2011) 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary, Journal of the American College of Cardiology, 10.1016/j.jacc.2011.10.825, 58:25, (2703-2738), Online publication date: 1-Dec-2011. Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J, Yancy C, Jacobs A, Smith S, Anderson J, Albert N, Buller C, Creager M, Ettinger S, Guyton R, Halperin J, Hochman J, Krumholz H, Kushner F, Nishimura R, Ohman E, Page R, Stevenson W, Tarkington L and Yancy C (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2011.10.020, 142:6, (e153-e203), Online publication date: 1-Dec-2011. Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J, Yancy C, Jacobs A, Smith S, Anderson J, Albert N, Buller C, Creager M, Ettinger S, Guyton R, Halperin J, Hochman J, Krumholz H, Kushner F, Nishimura R, Ohman E, Page R, Stevenson W, Tarkington L and Yancy C (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2011.10.019, 142:6, (1303-1338), Online publication date: 1-Dec-2011. Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J and Yancy C (2011) 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy, Circulation, 124:24, (e783-e831), Online publication date: 13-Dec-2011.Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M, Naidu S, Nishimura R, Ommen S, Rakowski H, Seidman C, Towbin J, Udelson J and Yancy C (2011) 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary, Circulation, 124:24, (2761-2796), Online publication date: 13-Dec-2011. Alves M, Gaffin R and Wolska B (2010) Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes, Journal of Molecular and Cellular Cardiology, 10.1016/j.yjmcc.2010.01.003, 48:5, (834-842), Online publication date: 1-May-2010. Abdy N, Valdes S, Sorrell V, Klewer S and Barber B (2010) Apical Hypertrophic Cardiomyopathy in an Adolescent, Congenital Heart Disease, 10.1111/j.1747-0803.2009.00346.x, 5:2, (182-187), Online publication date: 1-Mar-2010. Schaff H, Brown M, Dearani J, Abel M, Ommen S, Sorajja P, Tajik A and Nishimura R (2010) Apical myectomy: A new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/j.jtcvs.2009.07.079, 139:3, (634-640), Online publication date: 1-Mar-2010. Calcagnino M and McKenna W (2010) Inherited Myocardial Diseases Heart Failure in Clinical Practice, 10.1007/978-1-84996-153-0_2, (21-76), . Coats C and Elliott P (2008) Current management of hypertrophic cardiomyopathy, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-008-0042-9, 10:6, (496-504), Online publication date: 1-Dec-2008. Fatkin D, Seidman J and Seidman C (2007) Hypertrophic Cardiomyopathy Cardiovascular Medicine, 10.1007/978-1-84628-715-2_59, (1261-1284), . Froehlich J and Eagle K (2007) Evaluation of Patients for Noncardiac Surgery Cardiovascular Medicine, 10.1007/978-1-84628-715-2_120, (2487-2499), . Sherrid M (2006) Pathophysiology and Treatment of Hypertrophic Cardiomyopathy, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2006.08.001, 49:2, (123-151), Online publication date: 1-Sep-2006. Gaasch W and Zile M (2004) Left Ventricular Diastolic Dysfunction and Diastolic Heart Failure, Annual Review of Medicine, 10.1146/annurev.med.55.091902.104417, 55:1, (373-394), Online publication date: 1-Feb-2004. Maron B, McKenna W, Danielson G, Kappenberger L, Kuhn H, Seidman C, Shah P, Spencer W, Spirito P, Ten Cate F, Wigle E, Vogel R, Abrams J, Bates E, Brodie B, Danias P, Gregoratos G, Hlatky M, Hochman J, Kaul S, Lichtenberg R, Lindner J, O'rourke R, Pohost G, Schofield R, Tracy C, Winters W, Klein W, Priori S, Alonso-Garcia A, Blomström-Lundqvist C, De Backer G, Deckers J, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S and Torbicki A (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy, Journal of the American College of Cardiology, 10.1016/S0735-1097(03)00941-0, 42:9, (1687-1713), Online publication date: 1-Nov-2003. Sherrid M, Chaudhry F and Swistel D (2003) Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction, The Annals of Thoracic Surgery, 10.1016/S0003-4975(02)04546-0, 75:2, (620-632), Online publication date: 1-Feb-2003. Boon D, van Goudoever J, Huijskes R, Piek J and van Montfrans G (2002) Diagnostic value of simultaneous non-invasive continuous, ambulatory finger blood pressure and electrocardiogram monitoring in a patient with hypertrophic obstructive cardiomyopathy, Blood Pressure Monitoring, 10.1097/00126097-200212000-00007, 7:6, (329-333), Online publication date: 1-Dec-2002. Redfield M and Maniu C (2005) Diastolic dysfunction: insights into pathophysiology and pharmacotherapy, Expert Opinion on Pharmacotherapy, 10.1517/14656566.2.6.997, 2:6, (997-1008), Online publication date: 1-Jun-2001. Hamada M, Shigematsu Y, Hara Y, Suzuki M, Ohtsuka T, Hiasa G, Ogimoto A, Saeki H, Suzuki J and Hiwada K (2001) Antiarrhythmic Drug, Cibenzoline, can Directly Improve the Left Ventricular Diastolic Function in Patients With Hypertrophic Cardiomyopathy, Japanese Circulation Journal, 10.1253/jcj.65.531, 65:6, (531-538), . Montijano Cabrera Á, Bouzas Zubeldía B, Penas Lado M and McKenna W (2001) Estrategias terapéuticas en la miocardiopatía hipertrófica obstructiva sintomática, Revista Española de Cardiología, 10.1016/S0300-8932(01)76502-5, 54:11, (1311-1326), Online publication date: 1-Jan-2001. Sherrid M, Gunsburg D and Sharma A (2000) Medical treatment of hypertrophic cardiomyopathy, Current Cardiology Reports, 10.1007/s11886-000-0012-7, 2:2, (148-153), Online publication date: 1-Mar-2000. Clusin W and Anderson M (1999) Calcium Channel Blockers: Current Controversies and Basic Mechanisms of Action , 10.1016/S1054-3589(08)60473-1, (253-296), . Spirito P, Seidman C, McKenna W and Maron B (1997) The Management of Hypertrophic Cardiomyopathy, New England Journal of Medicine, 10.1056/NEJM199703133361107, 336:11, (775-785), Online publication date: 13-Mar-1997. Betocchi S, Piscione F, Losi M, Pace L, Boccalatte M, Perrone-Filardi P, Cappelli-Bigazzi M, Briguori C, Manganelli F, Ciampi Q, Salvatore M and Chiariello M (1996) Effects of Diltiazem on Left Ventricular Systolic and Diastolic Function in Hypertrophic Cardiomyopathy**This study was supported in part by Grant 18/1/57 1994–1995 from the Italian Ministry of University and Scientific Research (MURST 60%), Rome, Italy., The American Journal of Cardiology, 10.1016/S0002-9149(96)00336-0, 78:4, (451-457), Online publication date: 1-Aug-1996. Görnandt L, Bubenheimer P, Reindell H and Weisswange A (1996) Klinik der Kardiomyopathien Herzkrankheiten, 10.1007/978-3-642-97605-6_33, (797-871), . Leslie J and Tardiff B (1995) 12 Calcium channel blockers, Baillière's Clinical Anaesthesiology, 10.1016/S0950-3501(95)80060-3, 9:1, (181-205), Online publication date: 1-Mar-1995. Mörl H and Heun-Letsch C (1995) Hypertrophische obstruktive Kardiomyopathie (HOCM) Interventionen am Herzen, 10.1007/978-3-642-93558-9_21, (241-246), . Dalvi B (1994) Percutaneous radiofrequency ablation of the left bundle branch: An alternative modality of treatment for patients with hypertrophic obstructive cardiomyopathy, Medical Hypotheses, 10.1016/0306-9877(94)90139-2, 43:3, (141-144), Online publication date: 1-Sep-1994. Hosenpud J (1994) The Cardiomyopathies Congestive Heart Failure, 10.1007/978-1-4613-8315-4_13, (196-222), . Zack P and Blausey W (1994) Symptomatic Japanese-type apical hypertrophic cardiomyopathy in a non-Asian patient: Favorable response to treatment with verapamil, American Heart Journal, 10.1016/0002-8703(94)90639-4, 128:3, (613-616), Online publication date: 1-Sep-1994. Louie E and Edwards L (1994) Hypertrophic cardiomyopathy, Progress in Cardiovascular Diseases, 10.1016/S0033-0620(05)80036-2, 36:4, (275-308), Online publication date: 1-Jan-1994. Gistri R, Cecchi F, Choudhury L, Montereggi A, Sorace O, Salvadori P and Camici P (1994) Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(94)90404-9, 74:4, (363-368), Online publication date: 1-Aug-1994. Dilsizian V, Bonow R, Epstein S and Fananapazir L (1993) Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy, Journal of the American College of Cardiology, 10.1016/0735-1097(93)90193-5, 22:3, (796-804), Online publication date: 1-Sep-1993. Dimitrow P and Dubiel J (1993) Effects on left ventricular function of pindolol added to verapamil in hypertrophic cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(93)90797-G, 71:4, (313-316), Online publication date: 1-Feb-1993. Gilligan D, Chan W, Joshi J, Clarke P, Fletcher A, Krikler S and Oakley C (1993) A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy, Journal of the American College of Cardiology, 10.1016/0735-1097(93)90386-F, 21:7, (1672-1679), Online publication date: 1-Jun-1993. Carvalho J and Rigby M (1992) Hypertrophic cardiomyopathy, Progress in Pediatric Cardiology, 10.1016/1058-9813(92)90032-H, 1:4, (48-60), Online publication date: 1-Sep-1992. Bonow R, Maron B, Leon M, Cannon R and Epstein S (1991) Management of patients with hypertrophic cardiomyopathy Hemodynamics in Daily Practice, 10.1007/978-94-011-3820-8_10, (137-157), . Blanchard D and Ross J (1991) Hypertrophic cardiomyopathy: Prognosis with medical or surgical therapy, Clinical Cardiology, 10.1002/clc.4960140105, 14:1, (11-19), Online publication date: 1-Jan-1991. Bright J, Golden A, Gompf R, Walker M and Toal R (1991) Evaluation of the Calcium Channel-Blocking Agents Diltiazem and Verapamil for Treatment of Feline Hypertrophic Cardiomyopathy, Journal of Veterinary Internal Medicine, 10.1111/j.1939-1676.1991.tb03134.x, 5:5, (272-282), Online publication date: 1-Sep-1991. de Prada J, Zueco J, Ruano J, Martin-Duran R, Sanjose J, Colman T and Pajaron A (1991) Differences in response to single dose and steady-state therapy with verapamil in stable angina, International Journal of Cardiology, 10.1016/0167-5273(91)90296-2, 32:3, (339-345), Online publication date: 1-Sep-1991. Setaro J, Zaret B, Schulman D, Black H and Soufer R (1990) Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance, The American Journal of Cardiology, 10.1016/0002-9149(90)90937-V, 66:12, (981-986), Online publication date: 1-Oct-1990. Pelliccia F, Cianfrocca C, Romeo F and Reale A (1990) Hypertrophic cardiomyopathy: Long-term effects of propranolol versus verapamil in preventing sudden death in "low-risk" patients, Cardiovascular Drugs and Therapy, 10.1007/BF02026500, 4:6, (1515-1518), Online publication date: 1-Nov-1990. Epstein S (1990) Future Trends in Research in Hypertrophic Cardiomyopathy Advances in Cardiomyopathies, 10.1007/978-3-642-83760-9_17, (175-178), . Hopf R and Kaltenbach M (1990) Medical Treatment of Hypertrophic Cardiomyopathy Advances in Cardiomyopathies, 10.1007/978-3-642-83760-9_12, (103-121), . Yamakado T, Okano H, Higashiyama S, Hamada M, Nakano T and Takezawa H (1990) Effects of nifedipine on left ventricular diastolic function in patients with asymptomatic or minimally symptomatic hypertrophic cardiomyopathy., Circulation, 81:2, (593-601), Online publication date: 1-Feb-1990. Wagner J, Sax F, Weisman H, Porterfield J, McIntosh C, Weisfeldt M, Snyder S and Epstein S (1989) Calcium-Antagonist Receptors in the Atrial Tissue of Patients with Hypertrophic Cardiomyopathy, New England Journal of Medicine, 10.1056/NEJM198903233201202, 320:12, (755-761), Online publication date: 23-Mar-1989. Opie L and Coetzee W (1989) Use and Comparative Efficacy in Hypertension and Supraventricular Arrhythmias. Minor Indications Clinical Use of Calcium Channel Antagonist Drugs, 10.1007/978-1-4613-0863-8_4, (131-192), . Mohr R, Schaff H, Danielson G, Puga F, Pluth J and Tajik A (1989) The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/S0022-5223(19)34512-X, 97:5, (666-674), Online publication date: 1-May-1989. Reindell H, Görnandt L and Bubenheimer P (1989) Klinik der Kardiomyopathien Herzkrankheiten, 10.1007/978-3-642-97060-3_48, (1073-1145), . Frenneaux M, Porter A, Caforio A, Odawara H, Counihan P and McKenna W (1989) Determinants of exercise capacity in hypertrophic cardiomyopathy, Journal of the American College of Cardiology, 10.1016/0735-1097(89)90342-2, 13:7, (1521-1526), Online publication date: 1-Jun-1989. Udelson J, Bonow R, O'Gara P, Maron B, Van Lingen A, Bacharach S and Epstein S (1989) Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy., Circulation, 79:5, (1052-1060), Online publication date: 1-May-1989. Pollick C (1988) Disopyramide in hypertrophic cardiomyopathy II. Noninvasive assessment after oral administration, The American Journal of Cardiology, 10.1016/0002-9149(88)90269-X, 62:17, (1252-1255), Online publication date: 1-Dec-1988. Hanyok J, Chow M, Kluger J and Izard M (2013) An Evaluation of the Pharmacokinetics, Pharmacodynamics, and Dialyzability of Verapamil in Chronic Hemodialysis Patients, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1988.tb03224.x, 28:9, (831-836), Online publication date: 1-Sep-1988. Opie L (1988) Calcium channel antagonists part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications, Cardiovascular Drugs and Therapy, 10.1007/BF02125750, 1:6, (625-656), Online publication date: 1-Mar-1988. Bier A, Eichacker P, Sinoway L, Terribile S, Strom J and Keefe D (2016) Acute Cardiogenic Pulmonary Edema: Clinical and Noninvasive Evaluation, Angiology, 10.1177/000331978803900302, 39:3, (211-218), Online publication date: 1-Mar-1988. Shaffer E, Rocchini A, Spicer R, Juni J, Snider R, Crowley D and Rosenthal A (1988) Effects of verapamil on left ventricular diastolic filling in children with hypertrophic cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(88)90296-2, 61:6, (413-417), Online publication date: 1-Feb-1988. Sasson Z, Rakowski H and Wigle E (1988) Hypertrophic Cardiomyopathy, Cardiology Clinics, 10.1016/S0733-8651(18)30494-6, 6:2, (233-288), Online publication date: 1-May-1988. Hopf R and Kaltenbach M (1988) 10-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium antagonists New Aspects of Hypertrophic Cardiomyopathy, 10.1007/978-3-642-85369-2_22, (230-242), . Lydtin H and Trenkwalder P (1988) Indikationen für Calcium-Antagonisten Calcium-Antagonisten, 10.1007/978-3-662-06199-2_4, (68-229), . Betocchi S, Bonow R, Cannon R, Lesko L, Ostrow H, Watson R and Rosing D (1988) Relation between serum nifedipine concentration and hemodynamic effects in nonobstructive hypertrophie cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(88)91075-2, 61:10, (830-835), Online publication date: 1-Apr-1988. Hamer J (1987) Calcium antagonists Drugs for Heart Disease, 10.1007/978-1-4899-3294-5_3, (77-102), . Bryhn M and Eskilsson J (1987) Effects of verapamil on left ventricular diastolic function at rest and during isometric exercise in patients with hypertrophic cardiomyopathy, Clinical Cardiology, 10.1002/clc.4960100107, 10:1, (31-36), Online publication date: 1-Jan-1987. Khurmi N and Raftery E (1987) Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris, Cardiovascular Drugs and Therapy, 10.1007/BF02125837, 1:1, (81-87), Online publication date: 1-Jan-1987. Doiuchi J, Hamada M, Kokubu T and Ito T (1987) Comparative effects of calcium-channel blockers and beta-adrenergic blocker on early diastolic time intervals and a-wave ratio in patients with hypertrophic cardiomyopathy, Clinical Cardiology, 10.1002/clc.4960100106, 10:1, (26-30), Online publication date: 1-Jan-1987. Chatterjee K (1987) Calcium antagonist agents in hypertrophic cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(87)90095-6, 59:3, (B146-B152), Online publication date: 1-Jan-1987. Maron B, Bonow R, Cannon R, Leon M and Epstein S (1987) Hypertrophic Cardiomyopathy, New England Journal of Medicine, 10.1056/NEJM198704023161405, 316:14, (844-852), Online publication date: 2-Apr-1987. Lawson J (1987) Southwestern Internal Medicine Conference: Hypertrophic Cardiomyopathy: Current Views on Etiology, Pathophysiology, and Management, The American Journal of the Medical Sciences, 10.1097/00000441-198709000-00011, 294:3, (191-210), Online publication date: 1-Sep-1987. Khurmi N and Raftery E (1987) A comparison of nine calcium ion antagonists and propranolol: Exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris, European Journal of Clinical Pharmacology, 10.1007/BF02455985, 32:6, (539-548), Online publication date: 1-Aug-1987. Fleg J (1986) When should digitalis be discontinued? Cardiac Glycosides 1785–1985, 10.1007/978-3-662-11292-2_72, (541-548), . Baughman K (1986) Calcium channel blocking agents in congestive heart failure, The American Journal of Medicine, 10.1016/0002-9343(86)90144-0, 80:2, (46-50), Online publication date: 1-Feb-1986. Lorimer A and Hillis W (1985) Cardiomyopathies Cardiovascular Disease, 10.1007/978-1-4471-3120-5_14, (257-270), . Shah P (1986) Controversies in hypertrophic cardiomyopathy, Current Problems in Cardiology, 10.1016/0146-2806(86)90002-2, 11:10, (565-613), Online publication date: 1-Oct-1986. Wilmshurst P, Thompson D, Juul S, Jenkins B and Webb-Peploe M (1986) Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy., Heart, 10.1136/hrt.56.6.544, 56:6, (544-553), Online publication date: 1-Dec-1986. Landmark K (2009) Hypertrophic Cardiomyopathy, Acta Pharmacologica et Toxicologica, 10.1111/j.1600-0773.1986.tb02533.x, 58:S2, (169-174) Paulus W, Nellens P, Heyndrickx G and Andries E (1986) Effects of long-term treatment with amiodarone on exercise hemodynamics and left ventricular relaxation in patients with hypertrophic cardiomyopathy., Circulation, 74:3, (544-554), Online publication date: 1-Sep-1986. Rosing D, Idänpään-Heikkilä U, Maron B, Bonow R and Epstein S (1985) Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(85)90630-7, 55:3, (B185-B195), Online publication date: 1-Jan-1985. Kaltenbach M and Hopf R (1985) Treatment of hypertrophic cardiomyopathy with beta blockers or calcium antagonists Recent Views on Hypertrophic Cardiomyopathy, 10.1007/978-94-009-4994-2_7, (101-113), . Wigle E, Sasson Z, Henderson M, Ruddy T, Fulop J, Rakowski H and Williams W (1985) Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review, Progress in Cardiovascular Diseases, 10.1016/0033-0620(85)90024-6, 28:1, (1-83), Online publication date: 1-Jul-1985. Lake C (1985) Pharmacology of Cardiac Drugs Cardiovascular Anesthesia, 10.1007/978-1-4612-5048-7_10, (239-288), . Kumar A and Elkayam U (1985) Hypertrophic Cardiomyopathy in Pregnancy Principles of Medical Therapy in Pregnancy, 10.1007/978-1-4613-2415-7_110, (695-697), . Cooper M, Shaddy R, Silverman N and Enderlein M (1985) Usefulness of Doppler echocardiography for determining hemodynamic improvement with intravenous verapamil in hypertrophic cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(85)90599-5, 56:1, (201-202), Online publication date: 1-Jul-1985. Bonow R (1985) Effects of calcium-channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease, The American Journal of Cardiology, 10.1016/0002-9149(85)90628-9, 55:3, (B172-B178), Online publication date: 1-Jan-1985. Doiuchi J, Hamada M, Ochi T, Ito T and Kokubu T (1985) Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy, Clinical Cardiology, 10.1002/clc.4960080311, 8:3, (176-179), Online publication date: 1-Mar-1985. Goodwin J (1985) Recent views on hypertrophic cardiomyopathy Recent Views on Hypertrophic Cardiomyopathy, 10.1007/978-94-009-4994-2_1, (1-8), . Bonow R, Dilsizian V, Rosing D, Maron B, Bacharach S and Green M (1985) Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects., Circulation, 72:4, (853-864), Online publication date: 1-Oct-1985.Betocchi S, Cannon R, Watson R, Bonow R, Ostrow H, Epstein S and Rosing D (1985) Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy., Circulation, 72:5, (1001-1007), Online publication date: 1-Nov-1985. Schwartz J, Jeang M, Raizner A, Griffin J and Wyndham C (1984) Accelerated junctional rhythms during oral verapamil therapy, American Heart Journal, 10.1016/0002-8703(84)90083-8, 107:3, (440-443), Online publication date: 1-Mar-1984. Anderson D, Raff G, Ports T, Brundage B, Parmley W and Chatterjee K (1984) Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function., Heart, 10.1136/hrt.51.5.523, 51:5, (523-529), Online publication date: 1-May-1984. Guerrero J and Martin S (1984) Verapamil: Full spectrum calcium channel blocking agent: An overview, Medicinal Research Reviews, 10.1002/med.2610040106, 4:1, (87-109), Online publication date: 1-Jan-1984. Vacek J, Davis W, Bellinger R and McKiernan T (1984) Apical hypertrophic cardiomyopathy in American patients, American Heart Journal, 10.1016/0002-8703(84)90698-7, 108:6, (1501-1506), Online publication date: 1-Dec-1984. Spicer R, Rocchini A, Crowley D and Rosenthal A (1984) Chronic verapamil therapy in pediatrie and young adult patients with hypertrophic cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(84)90589-7, 53:11, (1614-1619), Online publication date: 1-Jun-1984. McKenna W, Krikler D and Goodwin J (1984) Arrhythmias in Dilated and Hypertrophic Cardiomyopathy, Medical Clinics of North America, 10.1016/S0025-7125(16)31110-5, 68:4, (983-1000), Online publication date: 1-Jul-1984. Goodwin J (1984) Treatment of Cardiomyopathies Cardiology, 10.1007/978-1-4757-1824-9_8, (91-105), . Tendera M, Polonski L and Kozielska E (1983) Left Ventricular End-Diastolic Pressure-Volume Relationships in Hypertrophic Cardiomyopathy, Chest, 10.1378/chest.84.1.54, 84:1, (54-57), Online publication date: 1-Jul-1983. Hanrath P, Schlüter M, Sonntag F, Diemert J and Bleifeld W (1983) Influence of verapamil therapy on left ventricular performance at rest and during exercise in hypertrophic cardiomyopathy, The American Journal of Cardiology, 10.1016/0002-9149(83)90023-1, 52:5, (544-548), Online publication date: 1-Sep-1983. Lee T, Lilly L, Antman E, Disesa V and Cohn L (1983) Correction of intraoperative diastolic myocardial dysfunction with nifedipine, Clinical Cardiology, 10.1002/clc.4960061106, 6:11, (549-552), Online publication date: 1-Nov-1983. Tarnow J (1983) Pharmakologie und klinische Anwendung kreislaufwirksamer Medikamente Anaesthesie und Kardiologie in der
Referência(s)